Evidence map›Paper›PMID 32183496›Full record

ArticleNanomaterials (Basel, Switzerland)2020

Green and Economic Fabrication of Zinc Oxide (ZnO) Nanorods as a Broadband UV Blocker and Antimicrobial Agent.

Seyedeh-Masoumeh Taghizadeh, Neha Lal, Alireza Ebrahiminezhad, Fatemeh Moeini, Mostafa Seifan, Younes Ghasemi, Aydin Berenjian

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Green Synthesis of Zinc Oxide Nanoparticles (ZnO-NPs) UsingNanomaterials (Basel, Switzerland) · 2021
    Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Seyedeh-Masoumeh TaghizadehDepartment of Pharmaceutical Biotechnology, School of Pharmacy, and Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Neha LalSchool of Engineering, Faculty of Science and Engineering, The University of Waikato, Hamilton 3240, New Zealand.
Alireza EbrahiminezhadDepartment of Medical Nanotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.
Fatemeh MoeiniDepartment of Pharmaceutical Biotechnology, School of Pharmacy, and Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Mostafa SeifanSchool of Engineering, Faculty of Science and Engineering, The University of Waikato, Hamilton 3240, New Zealand.
Younes GhasemiDepartment of Pharmaceutical Biotechnology, School of Pharmacy, and Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Aydin BerenjianSchool of Engineering, Faculty of Science and Engineering, The University of Waikato, Hamilton 3240, New Zealand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zinc oxide (ZnO) nanoparticles have gained widespread interest due to their unique properties, making them suitable for a range of applications. Several methods for their production are available, and of these, controlled synthesis techniques are particularly favourable. Large-scale culturing of

Indexed as

antimicrobial activitybroadband UV blockerChlorella vulgariscontrolled synthesissecretory compoundszinc oxide nanorods

Identifiers

PMID32183496
PMCPMC7153581

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.